Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Ovarian Cancer × olaparib × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 93 Fallopian Tube Neoplasms 25 Breast Neoplasms 21 Endometrial Neoplasms 19 Carcinoma, Ovarian Epithelial 12 Prostatic Neoplasms 8 Pancreatic Neoplasms 8 Triple Negative Breast Neoplasms 7 Neoplasms 6 Fanconi Anemia, Complementation Group D1 5 Uterine Cervical Neoplasms 4 Recurrence 4 Neoplasm Metastasis 4 Carcinoma, Renal Cell 3 Uterine Neoplasms 2 Stomach Neoplasms 2 Peritoneal Neoplasms 2 Ovarian Diseases 2 Carcinosarcoma 2 Carcinoma, Non-Small-Cell Lung 2 Urogenital Neoplasms 1 Triple Negative Metastatic Breast Cancer 1 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Relapsed Ovarian Cancers Patients 1 Recurrent Ovarian High Grade Serous Adenocarcinoma 1 Prostatic Neoplasms, Castration-Resistant 1 Platinum-sensitive Ovarian Cancer 1 Platinum-Refractory Fallopian Tube Carcinoma 1

Interventions

Saline Solution 3 Carboplatin 2 Bevacizumab 2 talazoparib 1 stenoparib 1 senaparib 1 sargramostim 1 olaparib 1 niraparib 1 liposomal doxorubicin 1 Tranexamic Acid 1 Ropivacaine 1 Paclitaxel 1 Observation 1 Neoadjuvant Therapy 1 Hyperthermic Intraperitoneal Chemotherapy 1 Antineoplastic Agents 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03161132 2023-01-27

ROLANDO

Grupo Español de Investigación en Cáncer de Ovario

Phase 2 Completed

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡